lncRNA &lt;i&gt;NAS1&lt;/i&gt; Deficiency Drives Cisplatin Resistance via NR2F1-Mediated TGFB1/NF-κB Signaling Axis in NSCLC. This evidence concerns the gene NR2F1 and non-small cell lung carcinoma.